Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Efficacy of upadacitinib has been assessed in trials including Measure Up 1 (NCT03569293), Measure Up 2 (NCT03607422), and Heads Up (NCT03738397). Measure Up 1 and 2 assessed efficacy of upadacitinib 30 mg and upadacitinib 15 mg against placebo, while Heads Up assessed efficacy...

Descrición completa

Detalles Bibliográficos

Principais autores:	April W. Armstrong, H. Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, Jonathan I. Silverberg
Formato:	Artigo
Idioma:	Inglês
Publicado:	Adis, Springer Healthcare 2024-07-01
Series:	Dermatology and Therapy
Assuntos:	Upadacitinib Dupilumab Atopic dermatitis Indirect treatment comparison Skin clearance Pruritus
Acceso en liña:	https://doi.org/10.1007/s13555-024-01240-x
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!